The STEM-PD research team will now continue the long-term follow-up of the participants to further evaluate safety, graft function, and clinical benefit.

Scientists suggest that advanced aliens might not have physical bodies, challenging traditional views of extraterrestrial ...

Adobe’s creator report shows AI is speeding up creative work, but trust, disclosure, copyright, and human judgment may matter ...

Kenai Therapeutics, a clinical-stage biotechnology company pioneering next generation approaches to cure neurological conditions, today announced the completion of enrollment for the REPLACEtm Phase ...

Latest findings on neflamapimod to be featured in presentations demonstrating its impact on dementia with Lewy bodies (DLB) disease progression, ...

Oral PrimeC for ALS significantly reduced toxic TDP-43 protein levels in a Phase 2b trial. PrimeC also slowed functional decline and extended survival by about 15 months. The treatment was well ...

Aspen Neuroscience, Inc., a clinical-stage regenerative medicine biotechnology company developing personalized, autologous ...

Basel, July 2, 2026 – Novartis today announced that the European Commission (EC) has approved Itvisma ® (onasemnogene ...

Researchers have proposed a new explanation for the mechanism of development of Alzheimer's disease. The disease can begin with the displacement of tau protein from the microtubules of neurons under ...

Single neurons in mouse sensorimotor cortex are organized by their activity features into distinct subpopulations with area-spanning footprints whose boundaries align closely with anatomical and ...

A study recently published in the journal Nature provides evidence that individual brain cells in the human cortex act as ...